Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Détails
ID Serval
serval:BIB_34BED0C92D50
Type
Autre: (aucun autre type ne convient)
Collection
Publications
Institution
Titre
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Création de la notice
19/07/2024 8:44
Dernière modification de la notice
20/07/2024 6:06